Profiling gene transcription reveals a deficiency of mitochondrial oxidative phosphorylation in Trypanosoma cruzi-infected murine hearts: Implications in chagasic myocarditis development

Biochimica et Biophysica Acta - Molecular Basis of Disease

Volumn 1638, Issue 2, 2003, Pages 106-120

  Garg, Nisha ^a   Popov, Vsevolod L ^a   Papaconstantinou, John ^b  

^a University of Texas Medical Branch School of Medicine   (United States)

^b UNIVERSITY OF TEXAS MEDICAL BRANCH   (United States)

Author keywords

Animal model of human disease; Chagasic cardiomyopathy; Cytochrome c oxidase; Gene expression analysis; Oxidative phosphorylation; Oxidative stress

Indexed keywords

CYTOCHROME C OXIDASE; SCLEROPROTEIN; TROPONIN;

ACUTE PHASE RESPONSE; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CHAGAS DISEASE; CHRONICITY; CONTROLLED STUDY; CYTOCHROME C OXIDASE DEFICIENCY; DISEASE ASSOCIATION; DISEASE COURSE; DNA MICROARRAY; DNA REPLICATION; DNA TRANSCRIPTION; DOWN REGULATION; EXTRACELLULAR MATRIX; GENE EXPRESSION; GENE OVEREXPRESSION; GENE REPRESSION; GENETIC ANALYSIS; GENETIC CODE; GENETIC TRANSCRIPTION; HEART CONTRACTION; HEART DISEASE; HEART MUSCLE INJURY; HEART VENTRICLE HYPERTROPHY; HEART VENTRICLE REMODELING; MALE; MOUSE; NONHUMAN; OXIDATIVE PHOSPHORYLATION; OXIDATIVE STRESS; PRIORITY JOURNAL; PROTOZOAL INFECTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TRYPANOSOMA CRUZI; TRYPANOSOMIASIS; UPREGULATION; WESTERN BLOTTING;

ANIMALIA; MURINAE; TRYPANOSOMA; TRYPANOSOMA CRUZI;

EID: 0038306394     PISSN: 09254439     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0925-4439(03)00060-7     Document Type: Article

References (58)

1. World Health Organization, Chagas disease: tropical diseases progress in research, 1997-1998, WHO Technical Report Series (1999).
2. Rassi A. Jr., Rassi A., Little W.C. Chagas' heart disease. Clin. Cardiol. 23:2000;883-889.
3. Jones E.M., Colley D.G., Tostes S., Lopes E.R., Vnencak-Jones C.L., McCurley T.L. Amplification of a Trypanosoma cruzi DNA sequence from inflammatory lesions in human chagasic cardiomyopathy. Am. J. Trop. Med. Hyg. 48:1993;348-357.
4. Gomes Y.M. PCR and sero-diagnosis of chronic Chagas' disease. Biotechnological advances. Appl. Biochem. Biotechnol. 66:1997;107-119.
5. Reis M.M., Higuchi M.d.L., Benvenuti L.A., Aiello V.D., Gutierrez P.S., Bellotti G., Pileggi F. An in situ quantitative immunohistochemical study of cytokines and IL-2R+ in chronic human chagasic myocarditis: correlation with the presence of myocardial Trypanosoma cruzi antigens. Clin. Immunol. Immunopathol. 83:1997;165-172.
6. Higuchi M. Human chronic chagasic cardiopathy: participation of parasite antigens, subsets of lymphocytes, cytokines and microvascular abnormalities. Mem. Inst. Oswaldo Cruz. 94:1999;263-267.
7. Ben Younes-Chennoufi A., Hontebeyrie-Joskowicz M., Tricottet V., Eisen H., Reynes M., Said G. Persistence of Trypanosoma cruzi antigens in the inflammatory lesions of chronically infected mice. Trans. R. Soc. Trop. Med. Hyg. 82:1988;77-83.
8. Tarleton R.L., Grusby M.J., Postan M., Glimcher L.H. Trypanosoma cruzi infection in MHC-deficient mice: further evidence for the role of both class I- and class II-restricted T cells in immune resistance and disease. Int. Immunol. 8:1996;13-22.
9. Bellotti G., Bocchi E.A., de Moraes A.V., Higuchi M.L., Barbero-Marcial M., Sosa E., Esteves-Filho A., Kalil R., Weiss R., Jatene A., Pileggi F. In vivo detection of Trypanosoma cruzi antigens in hearts of patients with chronic Chagas' heart disease [published erratum appears in Am. Heart J. 1998 Mar; 135 (3): 550]. Am. Heart J. 131:1996;301-307.
10. Gavin J.B., Maxwell L., Edgar S.G. Microvascular involvement in cardiac pathology. J. Mol. Cell. Cardiol. 30:1998;2531-2540.
11. de Avalos S.V., Blader I.J., Fisher M., Boothroyd J.C., Burleigh B.A. Immediate/early response to Trypanosoma cruzi infection involves minimal modulation of host cell transcription. J. Biol. Chem. 277:2002;639-644.
12. Ropert C., Almeida I.C., Closel M., Travassos L.R., Ferguson M.A., Cohen P., Gazzinelli R.T. Requirement of mitogen-activated protein kinases and I kappa B phosphorylation for induction of proinflammatory cytokines synthesis by macrophages indicates functional similarity of receptors triggered by glycosylphosphatidylinositol anchors from parasitic protozoa and bacterial lipopolysaccharide. J. Immunol. 166:2001;3423-3431.
13. Laucella S.A., Rottenberg M.E., de Titto E.H. Role of cytokines in resistance and pathology in Trypanosoma cruzi infection. Rev. Argent. Microbiol. 28:1996;99-109.
14. Teixeira M.M., Gazzinelli R.T., Silva J.S. Chemokines, inflammation and Trypanosoma cruzi infection. Trends Parasitol. 18:2002;262-265.
15. Almeida I.C., Camargo M.M., Procopio D.O., Silva L.S., Mehlert A., Travassos L.R., Gazzinelli R.T., Ferguson M.A. Highly purified glycosylphosphatidylinositols from Trypanosoma cruzi are potent proinflammatory agents. EMBO J. 19:2000;1476-1485.
16. Almeida I.C., Gazzinelli R.T. Proinflammatory activity of glycosylphosphatidylinositol anchors derived from Trypanosoma cruzi: structural and functional analyses. J. Leukoc. Biol. 70:2001;467-477.
17. Coelho P.S., Klein A., Talvani A., Coutinho S.F., Takeuchi O., Akira S., Silva J.S., Canizzaro H., Gazzinelli R.T., Teixeira M.M. Glycosylphosphatidylinositol-anchored mucin-like glycoproteins isolated from Trypanosoma cruzi trypomastigotes induce in vivo leukocyte recruitment dependent on MCP-1 production by IFN-gamma-primed-macrophages. J. Leukoc. Biol. 71:2002;837-844.
18. Petkova S.B., Tanowitz H.B., Magazine H.I., Factor S.M., Chan J., Pestell R.G., Bouzahzah B., Douglas S.A., Shtutin V., Morris S.A., Tsang E., Weiss L.M., Christ G.J., Wittner M., Huang H. Myocardial expression of endothelin-1 in murine Trypanosoma cruzi infection. Cardiovasc. Pathol. 9:2000;257-265.
19. Petkova S.B., Huang H., Factor S.M., Pestell R.G., Bouzahzah B., Jelicks L.A., Weiss L.M., Douglas S.A., Wittner M., Tanowitz H.B. The role of endothelin in the pathogenesis of Chagas' disease. Int. J. Parasitol. 31:2001;499-511.
20. Plata F., Garcia Pons F., Eisen H. Antigenic polymorphism of Trypanosoma cruzi: clonal analysis of trypomastigote surface antigens. Eur. J. Immunol. 14:1984;392-399.
21. Avila H.A., Sigman D.S., Cohen L.M., Millikan R.C., Simpson L. Polymerase chain reaction amplification of Trypanosoma cruzi kinetoplast minicircle DNA isolated from whole blood lysates: diagnosis of chronic Chagas' disease. Mol. Biochem. Parasitol. 48:1991;211-221.
22. Centurion-Lara A., Barrett L., Van Voorhis W.C. Quantitation of parasitemia by competitive polymerase chain reaction amplification of parasite kDNA minicircles during chronic infection with Trypanosoma cruzi. J. Infect. Dis. 170:1994;1334-1339.
23. Sun J., Tarleton R.L. Predominance of CD8+ T lymphocytes in the inflammatory lesions of mice with acute Trypanosoma cruzi infection. Am. J. Trop. Med. Hyg. 48:1993;161-169.
24. Garg N., Tarleton R.L. Genetic immunization elicits antigen-specific protective immune responses and decreases disease severity in Trypanosoma cruzi infection. Infect. Immun. 70:2002;5547-5555.
25. Chomczynski P., Sacchi N. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal. Biochem. 162:1987;156-159.
26. Saito H., Patterson C., Hu Z., Runge M.S., Tipnis U., Sinha M., Papaconstantinou J. Expression and self-regulatory function of cardiac interleukin-6 during endotoxemia. Am. J. Physiol., Heart Circ. Physiol. 279:2000;H2241-H2248.
27. Eisen M.B., Spellman P.T., Brown P.O., Botstein D. Cluster analysis and display of genome-wide expression patterns. Proc. Natl. Acad. Sci. U. S. A. 95:1998;14863-14868.
28. Eisen M.B., Brown P.O. DNA arrays for analysis of gene expression. Methods Enzymol. 303:1999;179-205.
29. Trounce I.A., Kim Y.L., Jun A.S., Wallace D.C. Assessment of mitochondrial oxidative phosphorylation in patient muscle biopsies, lymphoblasts, and transmitochondrial cell lines. Methods Enzymol. 264:1996;484-509.
30. Bradford M.A. A rapid and sensitive method for quantitation of microgram quantities of protein utilizing the principle of protein-DNA binding. Anal. Biochem. 72:1976;248-254.
31. Jarreta D., Orus J., Barrientos A., Miro O., Roig E., Heras M., Moraes C.T., Cardellach F., Casademont J. Mitochondrial function in heart muscle from patients with idiopathic dilated cardiomyopathy. Cardiovasc. Res. 45:2000;860-865.
32. Paludan S.R. Synergistic action of pro-inflammatory agents: cellular and molecular aspects. J. Leukoc. Biol. 67:2000;18-25.
33. Paludan S.R., Malmgaard L., Ellermann-Eriksen S., Bosca L., Mogensen S.C. Interferon (IFN)-gamma and Herpes simplex virus/tumor necrosis factor-alpha synergistically induce nitric oxide synthase 2 in macrophages through cooperative action of nuclear factor-kappa B and IFN regulatory factor-1. Eur. Cytokine Netw. 12:2001;297-308.
34. Boehm U., Klamp T., Groot M., Howard J.C. Cellular responses to interferon-gamma. Annu. Rev. Immunol. 15:1997;749-795.
35. Brener Z., Gazzinelli R.T. Immunological control of Trypanosoma cruzi infection and pathogenesis of Chagas' disease. Int. Arch. Allergy Immunol. 114:1997;103-110.
36. Cunha-Neto E., Rizzo L.V., Albuquerque F., Abel L., Guilherme L., Bocchi E., Bacal F., Carrara D., Ianni B., Mady C., Kalil J. Cytokine production profile of heart-infiltrating T cells in Chagas' disease cardiomyopathy. Braz. J. Med. Biol. Res. 31:1998;133-137.
37. Towbin J.A., Bowles K.R., Bowles N.E. Etiologies of cardiomyopathy and heart failure. Nat. Med. 5:1999;266-267.
38. Bowles N.E., Bowles K.R., Towbin J.A. The "final common pathway" hypothesis and inherited cardiovascular disease. The role of cytoskeletal proteins in dilated cardiomyopathy. Herz. 25:2000;168-175.
39. Ackerman M.J., VanDriest S.L., Ommen S.R., Will M.L., Nishimura R.A., Tajik A.J., Gersh B.J. Prevalence and age-dependence of malignant mutations in the beta-myosin heavy chain and troponin T genes in hypertrophic cardiomyopathy: a comprehensive outpatient perspective. J. Am. Coll. Cardiol. 39:2002;2042-2048.
40. Daehmlow S., Erdmann J., Knueppel T., Gille C., Froemmel C., Hummel M., Hetzer R., Regitz-Zagrosek V. Novel mutations in sarcomeric protein genes in dilated cardiomyopathy. Biochem. Biophys. Res. Commun. 298:2002;116.
41. Natoli G., Costanzo A., Guido F., Moretti F., Bernardo A., Burgio V.L., Agresti C., Levrero M. Nuclear factor kB-independent cytoprotective pathways originating at tumor necrosis factor receptor-associated factor 2. J. Biol. Chem. 273:1998;31262-31272.
42. Vadlamani L., Abraham W.T. Insights into pathogenesis and treatment of cytokines in cardiomyopathy. Curr. Cardiol. Rep. 2:2000;120-128.
43. Muller-Werdan U., Engelmann H., Werdan K. Cardiodepression by tumor necrosis factor-alpha. Eur. Cytokine Netw. 9:1998;689-691.
44. Lenzo J.C., Fairweather D., Shellam G.R., Lawson C.M. Immunomodulation of murine cytomegalovirus-induced myocarditis in mice treated with lipopolysaccharide and tumor necrosis factor. Cell. Immunol. 213:2001;52-61.
45. Drew P.D., Franzoso G., Becker K.G., Bours V., Carlson L.M., Siebenlist U., Ozato K. NF kappa B and interferon regulatory factor 1 physically interact and synergistically induce major histocompatibility class I gene expression. J. Interferon Cytokine Res. 15:1995;1037-1045.
46. Drew P.D., Franzoso G., Carlson L.M., Biddison W.E., Siebenlist U., Ozato K. Interferon regulatory factor-2 physically interacts with NF-kappa B in vitro and inhibits NF-kappa B induction of major histocompatibility class I and beta 2-microglobulin gene expression in transfected human neuroblastoma cells. J. Neuroimmunol. 63:1995;157-162.
47. Hall B.S., Tam W., Sen R., Pereira M.E. Cell-specific activation of nuclear factor-kappaB by the parasite Trypanosoma cruzi promotes resistance to intracellular infection. Mol. Biol. Cell. 11:2000;153-160.
48. Sharov V.G., Todor A.V., Silverman N., Goldstein S., Sabbah H.N. Abnormal mitochondrial respiration in failed human myocardium. J. Mol. Cell. Cardiol. 32:2000;2361-2367.
49. Nanbu T., Nakakoshi T., Yonezawa K., Kitabatake A. Myocardial high-energy phosphate metabolism in patients with stable chronic dilated cardiomyopathy under a dobutamine-induced prolonged mild workload. Am. Heart J. 138:1999;641-645.
50. Ye Y., Gong G., Ochiai K., Liu J., Zhang J. High-energy phosphate metabolism and creatine kinase in failing hearts: a new porcine model. Circulation. 103:2001;1570-1576.
51. Beer M., Seyfarth T., Sandstede J., Landschutz W., Lipke C., Kostler H., von Kienlin M., Harre K., Hahn D., Neubauer S. Absolute concentrations of high-energy phosphate metabolites in normal, hypertrophied, and failing human myocardium measured noninvasively with (31)P-SLOOP magnetic resonance spectroscopy. J. Am. Coll. Cardiol. 40:2002;1267.
52. Sawyer D.B., Colucci W.S. Hasenfuss G., Marban E. Molecular Approaches to Heart Failure Therapy. 2000;262-284 Steinkopff, Darmstadt.
53. Wallace D.C. Mitochondrial defects in cardiomyopathy and neuromuscular disease. Am. Heart J. 139:2000;S70-S85.
54. Clerk A., Fuller S.J., Michael A., Sugden P.H. Stimulation of "stress-regulated" mitogen-activated protein kinases (stress-activated protein kinases/c-Jun N-terminal kinases and p38-mitogen-activated protein kinases) in perfused rat hearts by oxidative and other stresses. J. Biol. Chem. 273:1998;7228-7234.
55. Bueno O.F., De Windt L.J., Tymitz K.M., Witt S.A., Kimball T.R., Klevitsky R., Hewett T.E., Jones S.P., Lefer D.J., Peng C.F., Kitsis R.N., Molkentin J.D. The MEK1-ERK1/2 signaling pathway promotes compensated cardiac hypertrophy in transgenic mice. EMBO J. 19:2000;6341-6350.
56. Sugden P.H., Clerk A. Cellular mechanisms of cardiac hypertrophy. J. Mol. Med. 76:1998;725-746.
57. Sugden P.H. Signalling pathways in cardiac myocyte hypertrophy. Ann. Med. 33:2001;611-622.
58. Chuenkova M.V., Pereira M.A. The T. cruzi trans-sialidase induces PC12 cell differentiation via MAPK/ERK pathway. NeuroReport. 12:2001;3715-3718.